Introduction and Definition
An ectopic pregnancy occurs when a fertilised ovum implants and develops outside the uterine cavity, most commonly within the fallopian tube (around 97% of cases), but may also be located in the ovary, abdomen, cervix, caesarean section scar, interstitial portion of the tube, or uterine cornua in anomalous uteri NICE CKS.
Epidemiology and Risk Factors
In the UK, ectopic pregnancy affects approximately 11 per 1000 pregnancies, amounting to about 12,000 cases annually NICE CKS. Risk factors include tubal damage, maternal age over 35 years, smoking, and history of tubal disease, though no identifiable risk factors exist in about a third of women presenting with ectopic pregnancy NICE CKS. Women undergoing assisted reproductive technologies (ART) have a higher prevalence of ectopic pregnancies compared to the general population SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris.
Clinical Presentation
Typical symptoms include abdominal or pelvic pain, amenorrhoea or missed period, and vaginal bleeding NICE CKS. Less common signs and symptoms can involve gastrointestinal discomfort, dizziness, shoulder tip pain, urinary symptoms, cervical motion tenderness, pallor, abdominal distension, shock, and hypotension NICE CKS. These symptoms often mimic other conditions such as urinary tract infections or gastrointestinal illnesses, which necessitates careful clinical assessment NICE CKS.
Diagnosis
The diagnosis relies on confirming pregnancy followed by clinical examination for ectopic signs NICE CKS. Transvaginal ultrasound is the diagnostic investigation of choice for locating the pregnancy NICE CKS. In cases with a positive pregnancy test but no visible intrauterine or extrauterine pregnancy on scan—a pregnancy of unknown location—clinical monitoring is critical as such cases may represent an early intrauterine pregnancy, an early miscarriage, or an ectopic pregnancy NICE NG126. Serum hCG measurements should not be used alone to determine pregnancy location but can help assess trophoblastic activity and guide management; two hCG measurements approximately 48 hours apart are recommended NICE NG126. Clinical symptoms take precedence over serum hCG trends in management decisions NICE NG126. Women must be given clear information on warning signs and emergency access irrespective of initial findings NICE NG126.
Management Approaches
Management depends on the clinical stability of the woman, the size and viability of the ectopic pregnancy, and hCG levels NICE NG126. Options include expectant management, medical treatment with methotrexate, and surgical intervention NICE NG126. Expectant management is suitable for clinically stable, asymptomatic women with small ectopics (<35 mm), no fetal heartbeat, and low hCG levels (≤1000 IU/L), provided close follow-up is feasible NICE NG126. For women with hCG levels between 1500 and 5000 IU/L, options include methotrexate or surgery if criteria such as absence of significant pain, unruptured ectopic, and no intrauterine pregnancy are met NICE NG126. Methotrexate-treated women require serial hCG monitoring post-treatment to ensure resolution, with further assessment if hCG rises or plateaus NICE NG126. Surgical management, preferably laparoscopic, is indicated for ruptured ectopic pregnancies, significant pain, or when medical management is contraindicated or unsuccessful NICE NG126. Salpingectomy is recommended unless there are fertility preservation concerns, in which case salpingotomy may be considered with informed consent about the risk of requiring additional treatment NICE NG126. Anti-D immunoglobulin prophylaxis at 250 IU (50 micrograms) is recommended for rhesus-negative women undergoing surgical treatment, but not for those managed medically or conservatively NICE NG126.
Complications and Follow-up
Potential complications include tubal rupture with haemorrhagic shock, recurrent ectopic pregnancy, adverse effects from treatment interventions, and significant psychological impact such as anxiety and depression NICE CKS. Women treated surgically should have serial hCG monitoring until levels are undetectable, and all women with prior ectopic pregnancy should be informed they can self-refer to early pregnancy assessment services in future pregnancies NICE NG126.
Relation to Fertility Treatments
Fertility treatments like ART increase the risk of ectopic pregnancies, especially in women with prior tubal pathology SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris. Careful monitoring during ovulation induction is advised to minimize risks including ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris.
Guideline and Evidence Sources
This summary integrates recommendations from NICE Clinical Knowledge Summaries and NG126 guideline, which are based on systematic evidence review and expert consensus and are aligned with international bodies including RCOG NICE CKS,NICE NG126,NICE CKS. In addition, pharmacovigilance from Pergoveris SmPCs highlights reproductive risks in the context of ART SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris,SmPC Pergoveris. While not explicitly detailed here, professional guidelines from organizations such as FIGO, ACOG, SOGC, EBCOG, the WHO antenatal care models, and journals such as Obstetrics & Gynecology (TOG) and the American Journal of Obstetrics & Gynecology (AJOG), support similar clinical approaches emphasizing early detection, risk stratification, and individualized management to optimize outcomes and maternal safety.
Key References
- NICE CKS: Ectopic pregnancy
- NICE NG126: Ectopic pregnancy and miscarriage: diagnosis and initial management
- NICE CKS: Pregnancy (uncomplicated) - antenatal care
- SmPC: Pergoveris 450IU Pen
- SmPC: Pergoveris 150 IU/75 IU powder and solvent for solution for injection
- SmPC: Pergoveris 300IU Pen
- SmPC: Pergoveris 900IU Pen